NEW YORK: Access Pharmaceuticals has hired Edelman through December of this year to help promote its MuGard brand, a treatment for oral mucositis.
“We really feel it's a good time to get a serious PR campaign in the works for MuGard because it's a leading product for oral mucositis and the market is not that educated on treatments for oral mucositis,” said Christine Berni, director of investor relations at Access.
Access chose Edelman because it is "one of the best and we ...